Jefferson, BioResearch Product Faire™
Virtual Event: Thursday, August 20, 2020
Attendance is free for science professionals.
Click here for more event information
Click on the button below on 8/20
from 10am - 3pm to enter virtual event
Learn about new research techniques and technologies
Tags: Thomas Jefferson University, ThomJeff, 2020, Virtual
Researchers at Thomas Jefferson University are working hard to develop vaccines in an effort to fight some of the world’s toughest viruses and cancers. Back in 2017, Thomas Jefferson University was awarded a $30 million five-year contract over a five-year period to research safe vaccination solutions. Since then, university researchers have been developing strategies to find life changing answers to these global issues.
Read MoreTags: Thomas Jefferson University, Vaccine Technology, virus research, brain cancer treatment, biotechnology events
Thomas Jefferson receives over 40 million in National Institute of Health (NIH) research funding each year. One of the projects supported by the NIH since 2011 has been an investigation into DNA viruses. This study recently yielded new insight into the two states of a viral protein and revealed its function as a DNA-sensor. This finding may serve as a road map for developing anti-viral therapy for pathogenic DNA viruses.
Read More
Tags: Pennsylvania, Thomas Jefferson University, NIH funded Research Projects, Research Funding, Northeast Region, ThomJeff, TJU, viruses
Each year, The Sidney Kimmel Cancer Center (SKCC) at Jefferson University Hospital receives approximately $72 million in grants for cancer research from organizations such as Susan Komen for the Cure. This year the SKCC received a $3 million donation from Esperanza and David Neu in order to establish the Neu Center for Supportive Medicine and Cancer Survivorship. The purpose of the Neu Center is to serve as a comprehensive resource for psycho-social care and research.
Read MoreTags: Pennsylvania, Northeast, Thomas Jefferson University, cancer research, NIH funded Research Projects, Philadelphia, PA, NIH funding, Cancer Center, ThomJeff, cancer research funding, BioResearch Product Faire, NIH awards 2017, 2017 research funding
Lung cancer is one of the most common types of cancers and is responsible for the most cancer deaths each year. Due to its prevalence, lung cancer is a point of study for many researchers around the world. Just this year, researchers from the Sidney Kimmel Cancer Center at Thomas Jefferson University in Philadelphia have discovered that the gene Nitrilase 1 (Nit1) plays a large role in the proliferation of cancer cells.
Read MoreTags: Pennsylvania, Northeast, Thomas Jefferson University, cancer research, Philadelphia, PA, ThomJeff, 2016, BioResearch Product Faire, Nitrilase 1, lung cancer, Nit1
Parkinson's Disease is a devastating neurodegenerative disease that affects people's motor functions. As of today, there are no cures for Parkinson's Disease, and treatments are only able to alleviate symptoms. Researchers across the nation are heavily studying the disease, with the goal of learning more about the onset and progress of the disease to help scientists develop treatment methods.
Tags: Northeast, Thomas Jefferson University, Parkinson's Disease Research, Philadelphia, PA, ThomJeff, 2016, Parkinson's Disease, BioResearch Product Faire, GM1 ganglioside
Imagine finally getting a knee replacement after dealing with years of crippling pain, only to develop a staph, or MRSA, infection at the surgery site. Not only is the pain still present, perhaps even worse, but rest of the body’s health is now at risk as well.
Tags: Pennsylvania, Thomas Jefferson University, 2015, Philadelphia, BioResearch Product Faire Event, PA, NIH funding, NIH grants, ThomJeff
MicroRNA (miRNA) play an important role in controlling different processes that occur in cells through gene regulation. These small molecules are able to regulate many cellular processes by reducing target amounts in the cells. There are more than 1,900 locations in the human genome that are known to produce these miRNA molecules.
Bioresearchers at Thomas Jefferson University in Philadelphia recently uncovered 3,400 new locations in the human genome that also produce miRNA molecules, offering up more options for further research into the relationship between miRNA and disease.
Read MoreTags: Northeast, Thomas Jefferson University, 2015, Philadelphia, BioResearch Product Faire Event, PA, ThomJeff, miRNA, human genome
Researchers at Thomas Jefferson University may have found the ticket to helping men fight prostate cancer more efficiently and over a longer period of time. While prostate cancer is usually treatable in its early stages, men affected with cancer that has metastasized into their bones have a greatly reduced chance of fighting the deadly disease.
Read More
Tags: Pennsylvania, Thomas Jefferson University, cancer research, 2015, Philadelphia, BioResearch Product Faire Event, PA, ThomJeff
Earlier this year, the Thomas Jefferson University Medical School received a remarkable donation of $110 million dollars. This donation, from the Sidney Kimmel Foundation, renamed the medical school to the Sidney Kimmel Medical College at Thomas Jefferson University and will help enrich the school's facilities, students, faculty, and research.
Read MoreTags: Northeast, Thomas Jefferson University, 2015, Philadelphia, BioResearch Product Faire Event, PA, ThomJeff
